POTENTIAL OF PROSTAGLANDIN TRANSPORTER OATP2A1/SLCO2A1 AS A TARGET OF NOVEL ANTI-INFLAMMATORY DRUG

被引：0
|
作者：
Shimada, Hiroaki [1 ,2 ]
Nakanishi, Takeo [1 ]
Nakamura, Yoshinobu [1 ]
Iwaki, Masahiro [2 ]
Tamai, Ikumi [1 ]
机构：
[1] Kanazawa Univ, Dept Membrane Transport & Biopharmaceut, Fac Pharmaceut Sci, Inst Med Pharmaceut & Hlth Sci, Kanazawa, Ishikawa, Japan
[2] Kindai Univ, Fac Pharm, Dept Pharm, Higashiosaka, Osaka, Japan
来源：
DRUG METABOLISM AND PHARMACOKINETICS | 2017年 / 32卷 / 01期
关键词：
D O I：
10.1016/j.dmpk.2016.10.391
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P265
引用
收藏
页码：S102 / S103
页数：2
相关论文
共 50 条
  • [1] Impact of FDA-Approved Drugs on the Prostaglandin Transporter OATP2A1/SLCO2A1
    Kamo, Shunsuke
    Nakanishi, Takeo
    Aotani, Rika
    Nakamura, Yoshinobu
    Gose, Tomoka
    Tamai, Ikumi
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 106 (09) : 2483 - 2490
  • [2] Prostaglandin Transporter OATP2A1/SLCO2A1 Is Essential for Body Temperature Regulation during Fever
    Nakamura, Yoshinobu
    Nakanishi, Takeo
    Shimada, Hiroaki
    Shimizu, Junya
    Aotani, Rika
    Maruyama, Shio
    Higuchi, Kei
    Okura, Takashi
    Deguchi, Yoshiharu
    Tamai, Ikumi
    JOURNAL OF NEUROSCIENCE, 2018, 38 (24): : 5584 - 5595
  • [3] Contribution of Prostaglandin Transporter OATP2A1/SLCO2A1 to Placenta-to-Maternal Hormone Signaling and Labor Induction
    Inagaki, Mai
    Nishimura, Tomohiro
    Nakanishi, Takeo
    Shimada, Hiroaki
    Noguchi, Saki
    Akanuma, Shin-ichi
    Tachikawa, Masanori
    Hosoya, Ken-ichi
    Tamai, Ikumi
    Nakashima, Emi
    Tomi, Masatoshi
    ISCIENCE, 2020, 23 (05)
  • [4] A novel role for OATP2A1/SLCO2A1 in a murine model of colon cancer
    Nakanishi, Takeo
    Ohno, Yasuhiro
    Aotani, Rika
    Maruyama, Shio
    Shimada, Hiroaki
    Kamo, Shunsuke
    Oshima, Hiroko
    Oshima, Masanobu
    Schuetz, John D.
    Tamai, Ikumi
    SCIENTIFIC REPORTS, 2017, 7
  • [5] A novel role for OATP2A1/SLCO2A1 in a murine model of colon cancer
    Takeo Nakanishi
    Yasuhiro Ohno
    Rika Aotani
    Shio Maruyama
    Hiroaki Shimada
    Shunsuke Kamo
    Hiroko Oshima
    Masanobu Oshima
    John D. Schuetz
    Ikumi Tamai
    Scientific Reports, 7
  • [6] Prostaglandin transporter (OATP2A1/SLCO2A1) contributes to local disposition of eicosapentaenoic acid-derived PGE3
    Gose, Tomoka
    Nakanishi, Takeo
    Kamo, Shunsuke
    Shimada, Hiroaki
    Otake, Katsumasa
    Tamai, Ikumi
    PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2016, 122 : 10 - 17
  • [7] INTERACTION OF THE ANTIGLAUCOMA PROSTANOID LATANOPROST WITH THE PROSTAGLANDIN TRANSPORTER OATP2A1
    Kraft, M. E.
    Zolk, O.
    Welge-Luessen, U.
    Schloetzer-Schrehardt, U.
    Kruse, F. E.
    Glaeser, H.
    Mandery, K.
    Koenig, J.
    Fromm, M. F.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 68 : 3 - 3
  • [8] Roles of Organic Anion Transporting Polypeptide 2A1 (OATP2A1/SLCO2A1) in Regulating the Pathophysiological Actions of Prostaglandins
    Nakanishi, Takeo
    Tamai, Ikumi
    AAPS JOURNAL, 2018, 20 (01):
  • [9] Roles of Organic Anion Transporting Polypeptide 2A1 (OATP2A1/SLCO2A1) in Regulating the Pathophysiological Actions of Prostaglandins
    Takeo Nakanishi
    Ikumi Tamai
    The AAPS Journal, 20
  • [10] A novel mutation in the SLCO2A1 gene, encoding a prostaglandin transporter, induces chronic enteropathy
    Jimbo, Keisuke
    Okuno, Toshiaki
    Ohgaki, Ryuichi
    Nishikubo, Kou
    Kitamura, Yuri
    Sakurai, Yumiko
    Quan, Lili
    Shoji, Hiromichi
    Kanai, Yoshikatsu
    Shimizu, Toshiaki
    Yokomizo, Takehiko
    PLOS ONE, 2020, 15 (11):
12345